The New Standard
in Genetic Diagnostics
Our mission is to push the limits of genetic diagnostics providing patients and doctors the power to fight disease through high-precision early detection.
Get in touch
Founder of AleloPharma with over 20 years of experience in molecular genetics research and technology innovation and a solid track record in development, disclosing and licensing of front-end technologies for high-precision genetic analysis, edition and probing. Holds a Bachelor of Science degree from Universidad San Agustin and a Summa Cum Laude Ph.D. in Cell Biology and Genetics from Universidad Autonoma de Madrid.
Ph.D.
Co-Founder of AleloPharma with over 20 years of experience in the Biotech and Pharma industries in roles of increasing responsibility in Research, Business Development, Commercial Operations and General Management. Holds a Bachelor of Science degree from University Cayetano Heredia, a Ph.D. in Cell and Molecular Biology from the University of Notre Dame and a Master’s certificate in Business Administration from Tulane University.
Ph.D.
AleloMAXTM's innovative technology uses a proprietary chemistry design for unmatched ultra-specificity, unprecedented ultra-sensitivity and broad applicability in molecular probing, pathogen testing and biomarkers sensing. Unlike conventional molecular detection methods, AleloMAXTM uses an innovative synergistic probing system providing detection levels significantly superior to current on-market molecular diagnostic and monitoring systems. Powered by a novel molecular concordancy method and a bi-conditional connectives analytical algorithm, AleloMAXTM's expedient superiority offers surpassing resolution in today's molecular testing.